| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |